Rossari Biotech Limited (BOM:543213)

Rossari Biotech Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	-	442.02	251.7	691.98	374.77	152.08
Short-Term Investments	-	158.46	80.62	550.64	149.64	731.49
Trading Asset Securities	-	573.13	375.83	259.95	119.85	-
Cash & Short-Term Investments	1,174	1,174	708.15	1,503	644.26	883.57
Cash Growth	73.11%	65.73%	-52.87%	133.22%	-27.08%	-39.04%
Accounts Receivable	-	4,745	4,251	3,537	3,049	1,441
Other Receivables	-	2.82	1.54	5.41	1.16	10.15
Receivables	-	4,760	4,260	3,545	3,064	1,462
Inventory	-	3,551	2,823	1,885	1,899	953.54
Prepaid Expenses	-	20.11	12.48	18.31	49.49	4.93
Other Current Assets	-	914.46	631.99	263.62	436.26	243.43
Total Current Assets	-	10,419	8,436	7,214	6,093	3,547
Property, Plant & Equipment	-	4,937	3,619	3,267	3,480	1,682
Long-Term Investments	-	267.71	253.55	251.8	245.47	191.62
Goodwill	-	1,187	1,187	1,187	898.58	26.24
Other Intangible Assets	-	1,261	1,442	1,559	1,706	107.6
Long-Term Deferred Tax Assets	-	105.13	48.1	31.99	13.53	3.07
Other Long-Term Assets	-	784.41	736.46	164.48	130.46	55.86
Total Assets	-	18,962	15,722	13,676	12,567	5,613
Accounts Payable	-	2,863	2,191	1,810	1,862	1,311
Accrued Expenses	-	54.21	33.37	95.2	97.33	49.55
Short-Term Debt	-	861.12	625.28	290.12	-	-
Current Portion of Long-Term Debt	-	18.29	99.75	99.83	84.27	-
Current Portion of Leases	-	77.18	20.59	-	-	-
Current Income Taxes Payable	-	122.47	101.01	84.63	71.83	8.34
Current Unearned Revenue	-	3.61	3.9	4.19	4.48	-
Other Current Liabilities	-	1,365	1,173	1,101	827.22	132.84
Total Current Liabilities	-	5,366	4,247	3,485	2,947	1,502
Long-Term Debt	-	1,000	333.24	349.33	-	-
Long-Term Leases	-	223.07	109.06	-	-	-
Long-Term Deferred Tax Liabilities	-	465.67	514.72	587.2	689.49	12.88
Other Long-Term Liabilities	-	-	5.6	80.56	861.63	3.26
Total Liabilities	-	7,107	5,244	4,524	4,516	1,526
Common Stock	-	110.73	110.49	110.31	110.11	103.86
Additional Paid-In Capital	-	4,750	4,686	4,641	4,591	1,575
Retained Earnings	-	6,972	5,645	4,366	3,318	2,387
Comprehensive Income & Other	-	21.9	35.36	35.03	32.85	21.15
Shareholders' Equity	11,854	11,854	10,477	9,152	8,052	4,088
Total Liabilities & Equity	-	18,962	15,722	13,676	12,567	5,613
Total Debt	2,180	2,180	1,188	739.28	84.27	-
Net Cash (Debt)	-1,006	-1,006	-479.77	763.29	559.99	883.57
Net Cash Growth	-	-	-	36.30%	-36.62%	13.26%
Net Cash Per Share	-18.17	-18.17	-8.67	13.79	10.15	17.03
Filing Date Shares Outstanding	55.35	55.36	55.25	55.16	55.06	51.93
Total Common Shares Outstanding	55.35	55.36	55.25	55.16	55.06	51.93
Working Capital	-	5,054	4,188	3,729	3,146	2,045
Book Value Per Share	214.12	214.12	189.65	165.92	146.24	78.72
Tangible Book Value	9,406	9,406	7,849	6,405	5,447	3,954
Tangible Book Value Per Share	169.90	169.90	142.07	116.13	98.93	76.14
Land	-	101.42	101.42	101.42	101.42	101.23
Buildings	-	1,697	1,666	1,693	1,670	731.46
Machinery	-	2,904	2,379	2,114	2,056	1,260
Construction In Progress	-	1,402	472.09	130.72	13.42	3.19
Leasehold Improvements	-	81.02	-	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.